Prostate cancer (PC) is a leading cause of morbidity and mortality among men worldwide.
Molecular biomarkers work in conjunction with existing clinicopathologic tools to help …

Background This study aimed to evaluate the histopathological concordance rates between
prostate biopsies and radical prostatectomy specimens according to the applied biopsy …

Background Upgrading and/or upstaging in low-risk prostate cancer (PCa) patients may
represent an indication for active treatment instead of active surveillance (AS). We …

Background Only one previously published study by Nocera et al. addressed the risk of
upstaging to≥ pT3 in cT1 clear cell renal cell carcinoma (ccRCC) by using characteristics of …

Background Contemporary seminal vesicle invasion (SVI) rates in National Cancer
Comprehensive Network (NCCN) high‐risk prostate cancer (PCa) patients are not well …

We aimed to externally validate the SEER-based nomogram used to predict downgrading in
biopsied high-risk prostate cancer patients treated with radical prostatectomy (RP) in a …

Objectives There is a recent paradigm shift to extend robot-assisted radical prostatectomy
(RARP) to very senior prostate cancer (PCa) patients based on biological fitness …

In this study, we investigated the association between intraductal carcinoma of the prostate
(IDCP) along with several histopathological features on prostate biopsy and downgrading of …

Background To investigate the predictable parameters associated with downgrading in
patients with a Gleason score (GS) 8 (4+ 4) in prostate biopsy after radical prostatectomy …

Objective: To analyze the influence of biopsy Gleason score on the risk for lymph node
invasion (LNI) during pelvic lymph node dissection (PLND) in patients undergoing radical …